CVA Family Office LLC Has $38,000 Stake in Align Technology, Inc. (NASDAQ:ALGN)

CVA Family Office LLC grew its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 85.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 150 shares of the medical equipment provider’s stock after buying an additional 69 shares during the period. CVA Family Office LLC’s holdings in Align Technology were worth $38,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of ALGN. Vanguard Group Inc. grew its holdings in Align Technology by 0.3% during the first quarter. Vanguard Group Inc. now owns 8,375,147 shares of the medical equipment provider’s stock valued at $2,746,378,000 after purchasing an additional 25,362 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Align Technology by 1.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,148,282 shares of the medical equipment provider’s stock valued at $277,230,000 after buying an additional 15,540 shares during the period. Ninety One UK Ltd increased its position in shares of Align Technology by 1.0% in the 2nd quarter. Ninety One UK Ltd now owns 1,147,124 shares of the medical equipment provider’s stock valued at $276,950,000 after buying an additional 10,919 shares in the last quarter. Bares Capital Management Inc. lifted its holdings in Align Technology by 44.4% during the first quarter. Bares Capital Management Inc. now owns 819,930 shares of the medical equipment provider’s stock worth $268,871,000 after acquiring an additional 252,220 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN grew its stake in Align Technology by 0.5% in the second quarter. Disciplined Growth Investors Inc. MN now owns 707,542 shares of the medical equipment provider’s stock valued at $170,822,000 after acquiring an additional 3,600 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on ALGN shares. Morgan Stanley dropped their price target on Align Technology from $328.00 to $310.00 and set an “overweight” rating on the stock in a research report on Thursday, July 25th. StockNews.com upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a report on Thursday, September 19th. Evercore ISI reduced their price target on shares of Align Technology from $280.00 to $270.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Piper Sandler restated an “overweight” rating and set a $315.00 price objective on shares of Align Technology in a report on Friday, September 13th. Finally, Stifel Nicolaus cut their price objective on shares of Align Technology from $350.00 to $285.00 and set a “buy” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $295.00.

Insider Buying and Selling

In other Align Technology news, Director C Raymond Larkin, Jr. acquired 6,500 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were purchased at an average price of $235.33 per share, for a total transaction of $1,529,645.00. Following the completion of the purchase, the director now directly owns 28,247 shares of the company’s stock, valued at approximately $6,647,366.51. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.62% of the stock is currently owned by corporate insiders.

Align Technology Stock Performance

Shares of NASDAQ ALGN opened at $222.04 on Monday. The stock has a 50 day moving average price of $233.68 and a 200 day moving average price of $256.27. The stock has a market capitalization of $16.59 billion, a PE ratio of 37.70, a price-to-earnings-growth ratio of 5.33 and a beta of 1.64. Align Technology, Inc. has a 52 week low of $176.34 and a 52 week high of $335.40.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share for the quarter, beating the consensus estimate of $2.32 by $0.09. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. During the same period last year, the business earned $1.73 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. As a group, research analysts forecast that Align Technology, Inc. will post 7.61 EPS for the current year.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.